| Application no. and date | 19151897.6 (espacenet) (Federated) (European Patent Register), 20110124 | | Patent/reg. no. and date | DK/EP 3494972, 20231213 | | Publication date | 20190612 | | Priority no. and date | US 29858910 P, 20100127 | | EP pub. no. and date |
EP 3494972 20190612 | | Effective date | | | Applicant/owner | VIIV Healthcare Company, 251 Little Falls Drive
Wilmington, DE 19808, US | | Applicant ref. no. | V470018DK00 | | Inventor | UNDERWOOD, Mark Richard, c/o GlaxoSmithKline, Global Patents Dept
Five Moore Drive
Research Triangle Park
NC North Carolina 27709, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61K 31/5365 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 31/00 (2006.01) , A61P 31/12 (2006.01) , A61P 31/18 (2006.01) , A61P 37/04 (2006.01) , A61P 43/00 (2006.01) | | Title | Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2024 00022 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
